{"id":205433,"date":"2026-11-14T15:10:31","date_gmt":"2026-11-14T15:10:31","guid":{"rendered":"https:\/\/www.europesays.com\/dk\/205433\/"},"modified":"2026-11-14T15:10:31","modified_gmt":"2026-11-14T15:10:31","slug":"pfizer-innovent-glp-1-drugs-added-to-china-national-insurance-for-diabetes-china-news","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/dk\/205433\/","title":{"rendered":"Pfizer, Innovent GLP-1 drugs added to China national insurance for diabetes, China News"},"content":{"rendered":"<p>SHANGHAI\/BEIJING &#8211; GLP-1 drugs from Pfizer and Innovent Biologics will be added to China&#8217;s state-run health insurance scheme from Jan 1 for patients with type 2 diabetes, the National Healthcare Security Administration said on Saturday (Nov 14), in a fresh challenge to Danish rival Novo Nordisk.<\/p>\n<p>China has the highest number of adults with diabetes in the world, \u200baccording to an estimate by the International Diabetes Federation. Pfizer&#8217;s ecnoglutide and Innovent&#8217;s mazdutide belong to the class of GLP-1 \u200breceptor agonist drugs already included in China&#8217;s state insurance list from firms such \u200bas Novo, Eli Lilly and Guangzhou Innogen Pharmaceutical.<\/p>\n<p>Novo&#8217;s Ozempic joined China&#8217;s reimbursement list in \u200b2022, followed by Lilly&#8217;s Mounjaro and Innogen&#8217;s efsubaglutide alfa from this year for patients with \u200btype 2 diabetes. Inclusion in the national reimbursement list makes drugs more widely available \u200cin \u2060the country of 1.4 billion people, though an increase in sales volume often comes with lower prices.<\/p>\n<p>The GLP-1 class of weight drugs mimics a gut \u2060hormone to curb appetite and regulate blood sugar in patients with diabetes.<\/p>\n<p>Sales of Ozempic injector pens in the greater China region of mainland China, Taiwan and Hong Kong &#8211; Novo&#8217;s largest market after the US &#8211; slipped seven per cent to about 5.4 billion Danish crowns (S$1 billion) in 2025.<\/p>\n<p>Other treatments to be added to the list include two Eli Lilly drugs for ulcerative colitis and Crohn&#8217;s disease, as well as a CAR-T therapy from JW Therapeutics, according to company statements.<\/p>\n<p>The CAR-T therapy, which engineers patients&#8217; immune cells to recognise and kill cancer cells, was the first to be included in the reimbursement list.<\/p>\n<p>[[nid:751201]]<\/p>\n","protected":false},"excerpt":{"rendered":"SHANGHAI\/BEIJING &#8211; GLP-1 drugs from Pfizer and Innovent Biologics will be added to China&#8217;s state-run health insurance scheme&hellip;\n","protected":false},"author":2,"featured_media":205434,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_share_on_mastodon":"0"},"categories":[271],"tags":[174,15786,3335,90831,272,4131],"class_list":["post-205433","post","type-post","status-publish","format-standard","has-post-thumbnail","category-novo-nordisk","tag-china","tag-diabetes","tag-glp-1","tag-innovent","tag-novo-nordisk","tag-pfizer"],"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@dk\/117615435548751908","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/posts\/205433","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/comments?post=205433"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/posts\/205433\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/media\/205434"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/media?parent=205433"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/categories?post=205433"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/tags?post=205433"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}